Macupatide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Macupatide, covering 2026-03-02 to 2026-03-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes [Phase 2]